PDCD1 and neoplasm: It has been reported that the low density of tumor infiltrating lymphocytes (TILs), especially T cells and NK cells, may be associated with acquired resistance of anti-PD-1 immunotherapy (Sevenich, 2019; Kawashima et al., 2021).